1. Shang, Bin, Lu, Fengjuan, Jiang, Shujuan, Yang, Guanghai, Zhang, Hao. 2023. ALDOC promotes non-small cell lung cancer through affecting MYC-mediated UBE2N transcription and regulating Wnt/β-catenin pathway. In Aging, 15, 9614-9632. doi:10.18632/aging.205038. https://pubmed.ncbi.nlm.nih.gov/37724906/
2. Chen, Liqiao, Zeng, Yi, Ren, Baoqing, Zhang, Rupeng, Deng, Jingyu. 2023. ALDOC regulated the biological function and immune infiltration of gastric cancer cells. In The international journal of biochemistry & cell biology, 158, 106407. doi:10.1016/j.biocel.2023.106407. https://pubmed.ncbi.nlm.nih.gov/36997056/
3. De Vitis, Claudia, Battaglia, Anna Martina, Pallocca, Matteo, Mancini, Rita, Biamonte, Flavia. 2023. ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis. In Journal of experimental & clinical cancer research : CR, 42, 69. doi:10.1186/s13046-023-02641-0. https://pubmed.ncbi.nlm.nih.gov/36945054/
4. Chang, Yu-Chan, Chan, Ming-Hsien, Li, Chien-Hsiu, Tsai, Wen-Chiuan, Hsiao, Michael. 2024. PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression. In Cell communication and signaling : CCS, 22, 266. doi:10.1186/s12964-024-01645-3. https://pubmed.ncbi.nlm.nih.gov/38741139/
5. Ma, Zeqiang, Wang, Yingqian, Shen, Junnan, Zhu, Jiahua, Pang, Weijun. 2024. Overexpression of ALDOC Promotes Porcine Intramuscular and Intermuscular Fat Deposition by Activating the AKT-mTORC1 Signaling Pathway. In Journal of agricultural and food chemistry, 72, 23893-23907. doi:10.1021/acs.jafc.4c07781. https://pubmed.ncbi.nlm.nih.gov/39428631/
6. Chen, Xiaoying, Du, Yanhua, Broussard, Gerard Joey, Zhang, Xiaoqing, Bonni, Azad. 2022. Transcriptomic mapping uncovers Purkinje neuron plasticity driving learning. In Nature, 605, 722-727. doi:10.1038/s41586-022-04711-3. https://pubmed.ncbi.nlm.nih.gov/35545673/
7. Xu, Hang, Li, Yi-Fan, Yi, Xian-Yan-Ling, Yang, Lu, Ai, Jian-Zhong. 2023. ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression. In Military Medical Research, 10, 64. doi:10.1186/s40779-023-00500-9. https://pubmed.ncbi.nlm.nih.gov/38082365/
8. Fan, Kun, Wang, Jiwen, Sun, Wentao, Liu, Houbao, Liu, Han. 2020. MUC16 C-terminal binding with ALDOC disrupts the ability of ALDOC to sense glucose and promotes gallbladder carcinoma growth. In Experimental cell research, 394, 112118. doi:10.1016/j.yexcr.2020.112118. https://pubmed.ncbi.nlm.nih.gov/32502493/
9. Lao, Yuanxiang, Cui, Xiaohan, Xu, Zhu, Qin, Xihu, Sun, Beicheng. 2024. Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor microenvironment in hepatocellular carcinoma. In Journal of hepatology, 81, 847-861. doi:10.1016/j.jhep.2024.05.034. https://pubmed.ncbi.nlm.nih.gov/38825017/
10. Xu, Xiao, Chen, Yananlan, Shao, Shenye, Li, Changxian, Li, Xiangcheng. 2024. USP21 deubiquitinates and stabilizes HSP90 and ENO1 to promote aerobic glycolysis and proliferation in cholangiocarcinoma. In International journal of biological sciences, 20, 1492-1508. doi:10.7150/ijbs.90774. https://pubmed.ncbi.nlm.nih.gov/38385089/